Last updated on May 2020

Study to Evaluate the Safety and Efficacy of Lenacapavir in Combination With an Optimized Background Regimen in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance

Brief description of study

The primary objective of this study is to evaluate the antiviral activity of lenacapavir (formerly GS-6207) administered as an add-on to a failing regimen (functional monotherapy) in people living with HIV (PLWH) with multi-drug resistance (MDR).

Clinical Study Identifier: NCT04150068

Find a site near you

Start Over

Ruane Clinical Research Group Inc

Los Angeles, CA United States
  Connect »

Mills Clinical Research

Los Angeles, CA United States
  Connect »